Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects...
Day: April 17, 2025
Best Probiotics for Women Over 50 – Most Effective Probiotic Supplements for Menopause and Older Females 2025 – YourBiology
YourBiology YourBiology Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- As a health and wellness professional I get asked...
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
Strategic Collaboration Enhances Access to Cutting-Edge AI, Blockchain Solutions, Biopharma & Defense TechnologiesWEXFORD, Pa., April 17, 2025 (GLOBE NEWSWIRE) --...
Cardarine GW501516 SARMs: Cardarine Before & After Results, Benefits, Side Effects & Dosage – Buy Legal CrazyBulk Supplement
Cardarine GW501516 for sale. Is Cardarine Supplement Legal? Read This CrazyBulk CrazyBulk Albany, New York, April 17, 2025 (GLOBE NEWSWIRE)...
Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X
First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicationsEnhanced...
Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails
Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this SummerNEW YORK, April...
Hazelden Betty Ford Foundation Launches Next-Generation Model of Care and Quality
Industry-leading approach harnesses unique set of resources to improve quality in mental health and substance use treatmentCenter City, Minnesota--(Newsfile Corp....
Notice of General Meeting
April 17, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical...
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine...
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a...
Calcivis appoints Greg Sheehan as CEO
Greg Sheehan, Calcivis CEO Headshot of Greg Sheehan, CEO of Calcivis EDINBURGH, United Kingdom, April 17, 2025 (GLOBE NEWSWIRE) --...
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries
ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...
Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer
WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),...
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
WellStar Health System to Highlight New BVA-Driven Strategy That Significantly Reduces Kidney Injury Following LVAD Implantation Oak Ridge, TN, April...
Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025
PITTSBURGH, April 17, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced...
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...
Hydreight Technologies to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1×1 Meetings on Thursday, April 24, 2025
VANCOUVER, British Columbia and LAS VEGAS, April 17, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE:...
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of...